文献速递慢性肾脏病遗传性与小管间质肾病水电解质与酸碱

婴儿期高钙血症幸存者CYP24A1和SLC34A1突变的长期结局

Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

确诊20例IH,CYP24A1突变16例,SLC34A1突变4例。长期随访18例(平均年龄23.8岁),平均GFR 72 mL/min/1.73 m2,77%患者GFR<90,28%患者GFR<60,2例CYP24A1突变患者进展至终末期肾病并接受肾移植,88%患者存在肾钙质沉着。结论认为IH幸存者进展性慢性肾脏病和肾钙质沉着风险较高,需密切监测并早期预防。

要点

  • IH幸存者中77%存在GFR<90 mL/min/1.73 m2,28%存在GFR<60 mL/min/1.73 m2。
  • 88%的IH幸存者肾脏超声显示肾钙质沉着。
  • CYP24A1突变患者中2例进展至终末期肾病并接受肾移植。

核心结论

  • 婴儿期高钙血症幸存者具有进展性慢性肾脏病和肾钙质沉着的较高风险。
  • 建议对所有IH幸存者密切监测,并早期实施预防措施,如抑制维生素D3活性代谢物合成。

研究设计与样本

  • 所有患者进行IH相关基因突变分析、实验室检查和肾脏超声。
  • 长期结局在18例患者中评估,平均年龄23.8岁(范围2-34岁)。

主要发现

  • 20例确诊IH(10例女性),其中CYP24A1突变16例(8例女性),SLC34A1突变4例(2例女性)。
  • 18例长期随访患者平均GFR为72 mL/min/1.73 m2(范围15-105)。
  • 14例(77%)患者GFR<90 mL/min/1.73 m2,5例(28%)患者GFR<60 mL/min/1.73 m2,包括2例肾移植后成人。
  • 2例CYP24A1突变患者进展至终末期肾病并接受肾移植。
  • 18例中3例血清钙仍>2.6 mmol/L;16例(88%)肾脏超声显示肾钙质沉着;仅1例检测到轻度高钙尿症。

临床怎么用

  • 对IH幸存者应密切监测肾功能和肾脏影像学,早期发现CKD和肾钙质沉着。
  • 可考虑早期实施预防措施,如抑制活性维生素D3代谢物合成。

局限性

  • 长期结局仅评估18例患者,样本量较小。
  • 原文未报告IH在儿童中的发病率及ESRD风险水平。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Infantile hypercalcaemia (IH) is a vitamin D3 metabolism disorder. The molecular basis for IH is biallelic mutations in the CYP24A1 or SLC34A1 gene. These changes lead to catabolism disorders (CYP24A1 mutations) or excessive generation of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] (SLC34A1 mutations). The incidence rate of IH in children and the risk level for developing end-stage renal disease (ESRD) are still unknown. The aim of this study was to analyse the long-term outcome of adolescents and young adults who suffered from IH in infancy. DESIGN: Forty-two children (23 girls; average age 10.7 ± 6.3 years) and 26 adults (14 women; average age 24.2 ± 4.4 years) with a personal history of hypercalcaemia with elevated 1,25(OH)2D3 levels were included in the analysis. In all patients, a genetic analysis of possible IH mutations was conducted, as well as laboratory tests and renal ultrasonography. RESULTS: IH was confirmed in 20 studied patients (10 females). CYP24A1 mutations were found in 16 patients (8 females) and SLC34A1 in 4 patients (2 females). The long-term outcome was assessed in 18 patients with an average age of 23.8 years (age range 2-34). The average glomerular filtration rate (GFR) was 72 mL/min/1.73 m2 (range 15-105). Two patients with a CYP24A1 mutation developed ESRD and underwent renal transplantation. A GFR <90 mL/min/1.73 m2 was found in 14 patients (77%), whereas a GFR <60 mL/min/1.73 m2 was seen in 5 patients (28%), including 2 adults after renal transplantation. Three of 18 patients still had serum calcium levels >2.6 mmol/L. A renal ultrasound revealed nephrocalcinosis in 16 of 18 (88%) patients, however, mild hypercalciuria was detected in only one subject. CONCLUSIONS: Subjects who suffered from IH have a greater risk of progressive chronic kidney disease and nephrocalcinosis. This indicates that all survivors of IH should be closely monitored, with early implementation of preventive measures, e.g. inhibition of active metabolites of vitamin D3 synthesis.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Janiec A, Halat-Wolska P, Obrycki Ł, et al. Long-term outcome of the survivors of infantile hypercalcaemia with CYP24A1 and SLC34A1 mutations. Nephrol Dial Transplant. 2021. PMID: 33099630. doi:10.1093/ndt/gfaa178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。